e-SPACE Heart Failure 2023
Published: 25 October 2023
-
Views:
4279
-
Likes:
7
-
Views:
4279
-
Likes:
7
-
Up Next -
25m 15s
-
59m 4sPart 2 | Session 4 Plenary session 7 – Managing comorbidities in HF
-
1h 46sPart 2 | Session 5 Plenary session 8 – Devices in HF: time to reassess their place?
-
44m 24s
-
1h 1m 52sPart 2 | Session 7 Plenary session 9 – New technologies for HF management
-
1h 2m 8sPart 2 | Session 8 Plenary session 10 – Special Populations
-
1h 54sPart 1 | Session 1 Plenary session 1 – Recent guideline updates in HF Ahmed Bennis, Frieder Braunschweig, Marco Metra, Alicia Chan, Ovidiu Chioncel, Stefan Anker
-
41m 37sPart 1 | Session 2 Meet the expert – Iron Deficiency & IV Iron – The 2023 ESC HF Guidelines and Recent Trial Results: Interpretation & Implementation (Supported by an unrestricted educational grant from Pharmacosmos) Patricia Campbell, Paul Kalra, Robert Mentz
-
1h 8m 32sPart 1 | Session 3 Plenary session 2 – GDMT in the clinical setting Michael Böhm, Frieder Braunschweig, John JV McMurray, Gianluigi Savarese, Marianna Adamo
-
51m 41sPart 1 | Session 4 Special Live Interactive Session – Management of ATTR-CM Brett Sperry, Arnt Kristen, Fabian Knebel, Ahmad Masri
-
44m 4sPart 1 | Session 5 Meet the expert – Best practices in the management of patients with cardiac amyloidosis (Supported by an educational grant from AstraZeneca) Peter van der Meer, Daniela Tomasoni, Marianna Fontana
-
57m 43sPart 1 | Session 6 Plenary session 3 – SGLT2i in clinical practice Stefan Anker, Clara Saldarriaga, Milton Packer, Shelley Zieroth, Muthiah Vaduganathan, Deepak L Bhatt
-
40m 4sPart 1 | Session 7 Meet the expert – Management of patients with HFpEF: What did we learn from our HFrEF patients (Supported by an educational grant from AstraZeneca) Giuseppe Rosano, Clara Saldarriaga, Gianluigi Savarese
-
1h 1m 49sPart 1 | Session 8 Plenary session 4 – Obesity and weight management in HF Mikhail Kosiborod, Massimo Piepoli, Giulia Ferrannini, Wolfram Doehner, Mark Petrie
-
50m 39sPart 1 | Session 9 Special Live Interactive Session – Best practices for hyperkalemia management across the cardiorenal spectrum Giuseppe Rosano, Gianluigi Savarese, Ileana L Piña
-
56m 50sPart 1 | Session 10 Plenary session 5 – Worsening and acute heart failure Gerasimos Filippatos, Ileana L Piña, Marianna Adamo, Piotr Ponikowski, Javed Butler, John R Teerlink
-
36m 3sPart 2 | Session 1 Meet the expert – Iron deficiency and heart failure – what we have learnt so far? (Supported by an unrestricted educational grant from CSL Vifor) Ovidiu Chioncel, Piotr Ponikowski, Andrew Sindone
Overview
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.
A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Piotr Ponikowski
Head of the Department of Heart Diseases
Piotr Ponikowski is Head of the Department of Heart Diseases, Wroclaw Medical University and Head of the Cardiology Department at the Center for Heart Diseases at 4th Military Hospital, Wroclaw, Poland. His research interests mainly include heart failure (HF), coronary artery disease and cardiac arrhythmias. He has been involved in numerous research projects, such as the benefits of physical rehabilitation in patients with chronic HF, assessment of metabolic derangements in HF (with special interest in iron deficiency), evaluation of reflex control in the cardiorespiratory system in order to optimise assessment and management of patients with HF. He has been involved in numerous clinical trials as main investigator, member of international steering committees, endpoint committees and advisory boards.
Yuhui Zhang
Dr Yuhui Zhang is vice director of the Heart Failure Center and HFCU at Beijing Fuwai hospital, National Center for Cardiovascular Diseases in China.
She is secretary-general of the Chinese Heart Failure Association, the China National Heart Failure Society, the National HF Quality Control, the HF Medical Consortium, the Heart Failure specialist center Project, the China International Heart Failure Congress and of the Heart Failure Forum of China Heart Congress.
Dr Yuhui Zhang is an Editorial Board member of Cardiac Failure Review and may be contactable here.
Ewa Jankowska
Prof Ewa Jankowska is Professor of Medicine and Head of Laboratory of Applied Research on Cardiovascular System at the Department of Heart Diseases, Wroclaw Medical University, Poland. Her clinical and research interests include the role of peripheral mechanisms in the progression of heart failure, co-morbidities in heart failure, and experimental model of tachycardia-induced cardiomyopathy.
Prof Jankowska is an Editorial Board member of Cardiac Failure Review.
John GF Cleland
Professor of Cardiology
Prof John Cleland is a Professor of Cardiology at University of Glasgow, Glasgow, UK.
In 1977, he qualified from the University of Glasgow, completed training at St. Mary's & Hammersmith Hospitals (London) and was awarded a Senior Fellowship by the British Heart Foundation.
His main interests include heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines.
He founded the European Journal of Heart Failure and is Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure.
Stephan Von Haehling
Professor of Cardiology and Consultant Cardiologist
Prof Stephan von Haehling is a Professor of Cardiology and Consultant Cardiologist at University Medicine Göttingen, Göttingen, DE.
His PhD was awarded by Imperial College, London, UK after he completed studies on inflammatory mechanisms of heart failure at the National Heart and Lung Institute in London.
Prof von Haehling is a Fellow of the European Society of Cardiology and of the Heart Failure Association of the ESC. His research interests include the pathophysiology and the co-morbidities of heart failure, with particular focus on muscle wasting, biomarkers, and novel treatments.
Comments